- Home
- NTHI vs PROF Comparison
NTHI vs PROF Comparison
Compare NTHI & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTHI
- PROF
- Stock Information
- Founded
- NTHI 2008
- PROF N/A
- Country
- NTHI United States
- PROF Canada
- Employees
- NTHI N/A
- PROF N/A
- Industry
- NTHI Biotechnology: Pharmaceutical Preparations
- PROF Medical/Dental Instruments
- Sector
- NTHI Health Care
- PROF Health Care
- Exchange
- NTHI Nasdaq
- PROF Nasdaq
- Market Cap
- NTHI 155.4M
- PROF 134.3M
- IPO Year
- NTHI N/A
- PROF N/A
- Fundamental
- Price
- NTHI $9.88
- PROF $3.96
- Analyst Decision
- NTHI
- PROF Strong Buy
- Analyst Count
- NTHI 0
- PROF 1
- Target Price
- NTHI N/A
- PROF $11.00
- AVG Volume (30 Days)
- NTHI 72.4K
- PROF 175.2K
- Earning Date
- NTHI 08-19-2025
- PROF 11-06-2025
- Dividend Yield
- NTHI N/A
- PROF N/A
- EPS Growth
- NTHI N/A
- PROF N/A
- EPS
- NTHI N/A
- PROF N/A
- Revenue
- NTHI $59,990.00
- PROF $11,840,000.00
- Revenue This Year
- NTHI N/A
- PROF $60.07
- Revenue Next Year
- NTHI N/A
- PROF $121.80
- P/E Ratio
- NTHI N/A
- PROF N/A
- Revenue Growth
- NTHI N/A
- PROF 59.81
- 52 Week Low
- NTHI $3.20
- PROF $3.76
- 52 Week High
- NTHI $25.00
- PROF $9.17
- Technical
- Relative Strength Index (RSI)
- NTHI N/A
- PROF 30.10
- Support Level
- NTHI N/A
- PROF $3.76
- Resistance Level
- NTHI N/A
- PROF $4.69
- Average True Range (ATR)
- NTHI 0.00
- PROF 0.19
- MACD
- NTHI 0.00
- PROF -0.03
- Stochastic Oscillator
- NTHI 0.00
- PROF 18.60
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.